Genetics Articles | Today's Clinical Lab

The younger patients, especially those between the ages of five and eight, responded best to the treatment.

Gene Therapy Restored Hearing in Deaf Patients

Karolinska Institutet

New gene therapy well-tolerated and improves hearing in all 10 patients with congenital deafness or severe hearing impairment

Rapid in-house companion diagnostics can transform lab workflows and help pharma reach more patients, faster.

FDA Approves NGS Companion Diagnostic for ZEGFROVY and Tumor Profiling

Thermo Fisher Scientific

Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer generates results in as little as 24 hours to support timely therapy decisions

Females have two X chromosomes, males have one X and one Y chromosome, and it is common for males to lose the Y chromosome in some of their cells as they age.

Loss of Y Chromosome Leads to Poor Cancer Outcomes

Cedars-Sinai Medical Center

New findings could lead to improved immunotherapy options for male patients

The custom solutions program aims to build new, bespoke tools and solutions that serve as a springboard for customer innovation, enabling them to design, build, test, and iterate more quickly.

Integrated DNA Technologies Installs Custom Solutions Program to Accelerate Innovation in Synthetic Biology

Integrated DNA Technologies

White glove manufacturing service aims to enhance design-build-test cycle and drive rapid innovation

“This study shows the promise of MCED tests in detecting cancers very early, and sets the benchmark sensitivities required for their success.”

Cancers Can Be Detected in the Bloodstream 3 Years Prior to Diagnosis

Johns Hopkins Medicine

Detecting cancers years before their clinical diagnosis could help provide management with a more favorable outcome

Photo of a young Black woman scientist wearing PPE and using a microscope to examine breast cancer tissues in a clinical laboratory.

South African Study Identifies 2 New Breast Cancer Genes in Black Women

University of the Witwatersrand

Genetic factors contribute to some 30 percent of breast cancer cases in South Africa, necessitating investment in genomic research in African contexts

An illustration of many small, colorful rectangles on a black background to represent data generated from a genetics DNA sequence mapping.

Introducing a New Single-Cell Multiomics Workflow for Sequencing-Ready Libraries in Less than 10 Hours

Tecan, BioSkryb Genomics

The new workflow enables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing applications in cancer research, drug development, and precision medicine

Illustration of the structure of a DNA double-helix molecule in white against a blue background, representing direct in sample sequencing technology.

Element Biosciences Accelerates Rollout of Direct in Sample Sequencing for the AVITI24™ Intelligent Multiomics System to Meet Growing Demand

Element Biosciences

Direct in sample sequencing, or DISS, is a high-demand and transformative technology that unlocks library-prep free research possibilities across a variety of new use cases

Photo of blood test tubes stored in a tube rack on a laboratory bench awaiting next-generation sequencing for cancer research.

Integrated DNA Technologies Introduces New Hybridization Capture Solution to Accelerate Cancer Research

Integrated DNA Technologies

New xGen™ hybridization and wash offering is poised to revolutionize targeted next generation sequencing workflows

Optimizing Genetic Health Risk Testing: The Power of Preanalytical Systems

Today's Clinical Lab

Join Today’s Clinical Lab with experts from Targeted Genomics and DNA Genotek for an in-depth discussion on the role of Genetic Health Risk Tests (GHR) in advancing personalized healthcare, and how integrating sample collection devices validated for their analytical performance can enhance the reliability and accessibility of GHRs

UK and European Experts Release Landmark Clinical Guidance for Breast Cancer Prevention

Antegenes

This new publication sets the standard, enabling more personalized and targeted breast cancer prevention and detection

Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases

Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based Solutions

Cepheid, Oxford Nanopore Technologies

Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases

Illustration of thousands of people gathered in the shape of a DNA double helix against a blue background.

We Must Not Ignore Eugenics in Our Genetics Curriculum, Says Biology Professor

Cell Press

Professor Mark Peifer explains why understanding the history of eugenics is critical for up-and-coming scientists

Different colored patterns of genetic sequencing results in a clinical laboratory setting during a newborn screening research project.

Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England

Revvity

New agreement to support newborn health adds sequencing lab services to the existing extraction services collaboration

A close up photo of the gloved hand of a laboratory professional loading a genetic testing sample into lab instrument for cancer variant testing.

New Approaches to Cancer Variant Classification: Challenges and Opportunities

Marcy Richardson, PhD

Large-scale functional studies are emerging that offer promise to improve variant interpretation

Illustration of a DNA helix molecule with DNA base pairs ready for epigenome editing.

Rewiring Biological Time and Aging with Epigenome Editing

Charles A. Gersbach, PhD

The bright, new future of therapeutic epigenome editing is already on our doorstep

Photo of two fingers turning a dice, which changes the word from "negative" to "positive.”

Scientists Uncover How Retinoic Acid ‘Treats’ Neuroblastoma

Today's Clinical Lab

Researchers reveal how retinoic acid works against metastatic neuroblastoma, offering new insights into its role in treatment and paving the way for future therapies

Illustration of cancer cells releasing circulating tumor DNA (ctDNA), which can be analyzed via blood-based genetic testing to identify mutations in childhood cancers.

UK’s Precision Medicine Program Uses Blood Tests to Advance Childhood Cancer Treatments

Today's Clinical Lab

The first phase of the Stratified Medicine Paediatrics program shows that ctDNA blood tests can provide crucial insights for targeting treatments and tracking childhood cancer progression

No Cold Storage, No Hassle—Precision PCR with Lyophilized Beads

Promega

Improve accuracy, reduce contamination, and keep up with high-throughput demands using room-temperature stable PCR reagents

Illustration of a double helix representing genetic material against a blue background.

AlidaBio Launches EpiPlex™ Platform to Advance Epitranscriptomic Research

AlidaBio

EpiPlex is first platform to offer multitarget, quantitative analysis of RNA modifications to provide comprehensive detection and characterization of the epitranscriptome